Congress may try to let military veterans use ibogaine (an illegal plant medicine) to treat addiction or PTSD through a special amendment. The DEA (the US drug enforcement agency) will file official written testimony against this, citing two concerns: ibogaine can cause dangerous heart rhythm changes, and people might illegally sell it. The DEA does this routinely when Congress tries to bypass normal drug approval channels.
This is procedurally standard DEA behavior when Schedule I substances face legislative end-runs that bypass the formal scheduling review process. The dual objection framework (cardiac safety + diversion) gives DEA scientific credibility with members who might otherwise be sympathetic to veteran welfare framing. Four agents supported; dissent came from veteran advocates and MAPS researchers whose optimism is motivated. Resolution criterion is specific and publicly verifiable via committee testimony records or published agency correspondence.